Home
Conditions
Refractory Anemia

Clinical trial condition

Refractory Anemia

Explore clinical trials studying Refractory Anemia. Study availability and eligibility vary by location and protocol.

24 public trials 1 recruiting study

Refine in advanced search Browse all conditions

Refractory Anemia trial results

Completed

Pilot of Abatacept-based Immunosuppression for Prevention of Acute GvHD During Unrelated Donor HCT

NCT01012492

Conditions: ALL, AML, Anemia, +18 more
Locations: Boston Children's Hospital Boston, Massachusetts, United States

View Trial Details

Completed

Infusion of Off-the-Shelf Expanded Cord Blood Cells to Augment Cord Blood Transplant in Patients With Hematologic Malignancies

NCT01175785

Conditions: Accelerated Phase Chronic Myelogenous Leukemia, Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities, Adult Acute Myeloid Leukemia With Del(5q), +38 more
Locations: Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium Seattle, Washington, United States

View Trial Details

Completed

Differentiation Therapy With Decitabine in Treating Patients With Myelodysplastic Syndrome

NCT01165996

Conditions: Anemia, Anemia, Refractory, Anemia, Refractory, with Excess of Blasts, +23 more
Locations: Case Medical Center, University Hospitals Seidman Cancer Center, Case Comprehensive Cancer Center Cleveland, Ohio, United States

Cleveland Clinic Taussig Cancer Institute, Case Comprehensive Cancer Center Cleveland, Ohio, United States

View Trial Details

Completed

Deferasirox in Treating Iron Overload Caused By Blood Transfusions in Patients With Hematologic Malignancies

NCT01273766

Conditions: Acute Undifferentiated Leukemia, Adult Acute Lymphoblastic Leukemia in Remission, Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities, +206 more
Locations: Comprehensive Cancer Center of Wake Forest University Winston-Salem, North Carolina, United States

View Trial Details

Completed

Vorinostat, Tacrolimus, and Methotrexate in Preventing GVHD After Stem Cell Transplant in Patients With Hematological Malignancies

NCT01789255

Conditions: Accelerated Phase Chronic Myelogenous Leukemia, Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities, Adult Acute Myeloid Leukemia With Del(5q), +176 more
Locations: University of Michigan University Hospital Ann Arbor, Michigan, United States

View Trial Details

Completed

MS-275 and GM-CSF in Treating Patients With Myelodysplastic Syndrome and/or Relapsed or Refractory Acute Myeloid Leukemia or Acute Lymphocytic Leukemia

NCT00462605

Conditions: Adult Acute Lymphoblastic Leukemia in Remission, Adult Acute Megakaryoblastic Leukemia (M7), Adult Acute Minimally Differentiated Myeloid Leukemia (M0), +56 more
Locations: Johns Hopkins University Baltimore, Maryland, United States

View Trial Details

Completed

Identification of de Novo Fanconi Anemia in Younger Patients With Newly Diagnosed Acute Myeloid Leukemia

NCT01146210

Conditions: Anemia, Anemia, Aplastic, Anemia, Hypoplastic, Congenital, +41 more
Locations: Children's Oncology Group Monrovia, California, United States

View Trial Details

Completed

A Pilot Study to Evaluate the Co-Infusion of Ex Vivo Expanded Cord Blood Cells With an Unmanipulated Cord Blood Unit in Patients Undergoing Cord Blood Transplant for Hematologic Malignancies

NCT00343798

Conditions: Accelerated Phase Chronic Myelogenous Leukemia, Acute Myeloid Leukemia With Multilineage Dysplasia Following Myelodysplastic Syndrome, Adult Acute Lymphoblastic Leukemia in Remission, +145 more
Locations: City of Hope Medical Center Duarte, California, United States

University of Colorado Cancer Center - Anschutz Cancer Pavilion Aurora, Colorado, United States

University of Colorado Denver, Colorado, United States

Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium Seattle, Washington, United States

View Trial Details

Completed

Lenalidomide in Treating Young Patients With Relapsed or Refractory Solid Tumors or Myelodysplastic Syndromes

NCT00104962

Conditions: Anemia, Anemia, Refractory, Anemia, Refractory, with Excess of Blasts, +13 more
Locations: COG Phase I Consortium Arcadia, California, United States

View Trial Details

Completed

Tipifarnib in Treating Patients With Myelodysplastic Syndromes

NCT00005845

Conditions: Anemia, Anemia, Refractory, Anemia, Refractory, with Excess of Blasts, +22 more
Locations: M D Anderson Cancer Center Houston, Texas, United States

View Trial Details

Refractory Anemia

Refractory Anemia trial results

Related conditions